Pharmacy Focus: Psychedelic Pharmacy - Investigating Ketamine for Chronic Pain Management, Addiction Treatment

Podcast

This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about ketamine and the future of the opioid epidemic.

This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about how investigative psychedelic treatments could help treat both chronic pain as well as addiction, and what this could mean for the future of the opioid epidemic.

Related Videos
man taking opioid pills sitting at a dark table - Image credit: rohane | stock.adobe.com
Cropped view of senior man playing with puzzles on table- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Related Content
Phytotherapy Has Myriad Uses In Clinical Practice

Phytotherapy Has Myriad Uses In Clinical Practice

April 3rd 2024
Article
Public Health Matters: Entrepreneurship, MedsPLUS Consulting, and Reaching Marginalized Communities

Public Health Matters: Entrepreneurship, MedsPLUS Consulting, and Reaching Marginalized Communities

April 25th 2024
Podcast
Little Pills, Big Risks: The Untold Dangers of Referring to Low-Dose Aspirin as 'Baby Aspirin’

Little Pills, Big Risks: The Untold Dangers of Referring to Low-Dose Aspirin as 'Baby Aspirin’

March 13th 2024
Article
Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

April 5th 2024
Podcast
Image credit: luchschenF | stock.adobe.com

Pharmacist Facilitation of Buprenorphine Can Start in the Emergency Department

January 9th 2024
Article
Image credit: nobeastsofierce | stock.adobe.com

Understanding the Impact of Allelic Gene Variants on Pediatric Pain Relief

January 9th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.